Ipsen SA

ISIN FR0010259150

WKN A0ESMG

Overview

Quote

GBP 90.90

03/04/2025 (gettex)

+0.71|+0.79%

daily change

52 weeks low/high

85.67

106.20

Description

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Show more Show less

Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals France

Chart

03/04/2024 - 03/04/2025

Add ETF for comparison

Show more chart settings

Financials

Key metrics

Market capitalisation, EUR	9,010.06 m
EPS, EUR	-
P/B ratio	2.20
P/E ratio	25.72
Dividend yield	1.12%

Income statement (2024)

Revenue, EUR	3,400.60 m
Net income, EUR	355.90 m
Profit margin	10.47%

What ETF is Ipsen SA in?

There are 267 ETFs which contain Ipsen SA. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ipsen SA is the L&G Pharma Breakthrough UCITS ETF.

Show entries

Search:

ETF	Weight	Investment focus	Holdings	TER	Fund size (in m EUR)	Return 1Y	ISIN
L&G Pharma Breakthrough UCITS ETF	2.53%	Equity World Health Care Innovation	37	0.49%	18	+6.83%	IE00BF0H7608
iShares EURO STOXX Small UCITS ETF	1.45%	Equity Europe Small Cap	92	0.40%	452	-0.11%	IE00B02KXM00
SPDR S&P Euro Dividend Aristocrats Screened UCITS ETF EUR Unhedged (Dist)	1.08%	Equity Europe Dividend	40	0.30%	7	+16.91%	IE00BYTH5T38
Amundi S&P Eurozone Dividend Aristocrat Screened UCITS ETF Acc	1.07%	Equity Europe Dividend	40	0.30%	8	+17.01%	LU0959210781
Amundi S&P Eurozone Dividend Aristocrat Screened UCITS ETF Dist	1.07%	Equity Europe Dividend	40	0.30%	19	+16.60%	LU0959210278
BNP Paribas Easy MSCI EMU SRI S-Series PAB 5% Capped UCITS ETF	0.86%	Equity Europe Social/Environmental	61	0.25%	94	+9.24%	LU1953137681
BNP Paribas Easy MSCI Europe SRI S-Series PAB 5% Capped UCITS ETF EUR Dis	0.71%	Equity Europe Social/Environmental	116	0.25%	179	+6.10%	LU1753045415
BNP Paribas Easy MSCI Europe SRI S-Series PAB 5% Capped UCITS ETF EUR Acc	0.71%	Equity Europe Social/Environmental	116	0.25%	40	+6.14%	LU1753045332
Fidelity Europe Quality Income UCITS ETF	0.67%	Equity Europe Dividend	89	0.35%	2	+10.49%	IE00BYSX4408
iShares STOXX Europe Small 200 UCITS ETF (DE)	0.67%	Equity Europe Small Cap	200	0.20%	546	+3.20%	DE000A0D8QZ7

Showing 1 to 10 of 267 entries

1 2 3 4 5…27

Performance

Returns overview

YTD	-1.45%
1 month	-1.82%
3 months	-3.61%
6 months	-3.22%
1 year	-0.78%
3 years	-7.12%
5 years	-
Since inception (MAX)	+35.77%
2024	-2.58%
2023	+4.76%
2022	+32.02%
2021	-

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).